CD79A and cancer: The top 10 pathways were “human T-cell leukemia virus 1 infection”, “chemokine signaling pathway”, “Th17 cell differentiation”, “NF-kappa B signaling pathway”, “Th1 and Th2 cell differentiation”, “T cell receptor signaling pathway”, “PD-L1 expression” and “PD-1 checkpoint pathway in cancer”, “Fc gamma R-mediated phagocytosis”, “inflammatory bowel disease”, and “intestinal immune network for IgA production”.